FMR LLC 13D and 13G filings for Stoke Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | Stoke Therapeutics, Inc. STOK | FMR LLC | 5,000 0.011% | -3,029,649 (-99.84%) | Filing |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | Stoke Therapeutics, Inc. STOK | FMR LLC | 3,034,649 7.696% | 479,850 (+18.78%) | Filing |
| 2022-02-09 10:01 am Sale | 2022-02-08 | 13G | Stoke Therapeutics, Inc. STOK | FMR LLC | 2,554,799 6.944% | -1,046,176 (-29.05%) | Filing |
| 2021-02-08 10:33 am Purchase | 2021-02-05 | 13G | Stoke Therapeutics, Inc. STOK | FMR LLC | 3,600,975 9.937% | 3,600,975 (New Position) | Filing |